(Q36594121)

15 August 2017

An inherited NBN mutation is associated with poor prognosis prostate cancer (English)

1 reference

15 August 2017

1 reference

B Małkiewicz

21

0 references

Tomasz Byrski

T Byrski

9

0 references

Anna Jakubowska

A Jakubowska

4

0 references

Cezary Cybulski

1

C Cybulski

1 reference

15 August 2017

39

J Lubiński

1 reference

15 August 2017

38

S A Narod

1 reference

15 August 2017

30

A Paradysz

1 reference

Polish Hereditary Prostate Cancer Consortium

15 August 2017

40

Polish Hereditary Prostate Cancer Consortium

1 reference

15 August 2017

Paulina Sikorska-Radek

23

P Sikorska-Radek

1 reference

15 August 2017

6

J Gronwald

1 reference

15 August 2017

7

T Huzarski

1 reference

15 August 2017

5

B Górski

1 reference

15 August 2017

2

D Wokołorczyk

1 reference

15 August 2017

10

T Dębniak

1 reference

15 August 2017

W Kluźniak

3

1 reference

15 August 2017

A Kashyap

8

1 reference

15 August 2017

A Gołąb

11

1 reference

15 August 2017

B Gliniewicz

12

1 reference

15 August 2017

A Sikorski

13

1 reference

15 August 2017

J Switała

14

1 reference

15 August 2017

T Borkowski

15

1 reference

15 August 2017

A Borkowski

16

1 reference

15 August 2017

A Antczak

17

1 reference

15 August 2017

L Wojnar

18

1 reference

15 August 2017

J Przybyła

19

1 reference

15 August 2017

M Sosnowski

20

1 reference

15 August 2017

R Zdrojowy

22

1 reference

15 August 2017

J Matych

24

1 reference

15 August 2017

J Wilkosz

25

1 reference

15 August 2017

W Różański

26

1 reference

15 August 2017

J Kiś

27

1 reference

15 August 2017

K Bar

28

1 reference

15 August 2017

P Bryniarski

29

1 reference

15 August 2017

K Jersak

31

1 reference

15 August 2017

J Niemirowicz

32

1 reference

15 August 2017

P Słupski

33

1 reference

15 August 2017

P Jarzemski

34

1 reference

15 August 2017

M Skrzypczyk

35

1 reference

15 August 2017

J Dobruch

36

1 reference

15 August 2017

P Domagała

37

1 reference

15 August 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

108

1 reference

15 August 2017

2

1 reference

15 August 2017

461-468

1 reference

Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Germline BRCA1 mutations increase prostate cancer risk

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Prostate-cancer mortality at 11 years of follow-up

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Germline mutations in HOXB13 and prostate-cancer risk

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Rapid progression of prostate cancer in men with a BRCA2 mutation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

CHEK2 variants associate with hereditary prostate cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Mutations in CHEK2 associated with prostate cancer risk

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Cancer Incidence in BRCA1 mutation carriers

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Biallelic inactivation of BRCA2 in Fanconi anemia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Chromosomal breakage syndromes and the BRCA1 genome surveillance complex

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Study of a single BRCA2 mutation with high carrier frequency in a small population

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Human genetic instability syndromes: single gene defects with increased risk of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

BRCA2 mutation in Icelandic prostate cancer patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

NBS1 is a prostate cancer susceptibility gene.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Growth retardation and tumour inhibition by BRCA1.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566821

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.486

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.486

Variation in BRCA1 cancer risks by mutation position

21 January 2018

1 reference

12 December 2020

Breast cancer predisposing alleles in Poland

1 reference

12 December 2020

Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel

1 reference

12 December 2020

Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies

1 reference

12 December 2020

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

1 reference

12 December 2020

Prostate-cancer mortality after PSA screening

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.486

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23149842

1 reference